ReviewCancers2025
Single-Port vs. Multi-Port Robotic Surgery in Urologic Oncology: A Comparative Analysis of Current Evidence and Future Directions.
Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Single-port versus multi-port robot-assisted partial nephrectomy for predominantly low-complexity renal tumors: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Comparative outcomes of da Vinci SP versus da Vinci Xi platforms in robotic cholecystectomy: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Adoption of single-port robot-assisted radical prostatectomy following multiport xi experience: lessons from a learning curve analysis.Journal of robotic surgery · 2026Article
- Patient positioning in robot-assisted pelvic urologic surgery: bibliometric mapping of physiologic changes, positioning-related complications, and preventive strategies.Journal of robotic surgery · 2026Article
- Feasibility and early outcomes of single-port robotic-assisted radical cystectomy with intracorporeal ileal conduit: an initial Spanish case series.Translational andrology and urology · 2026Article
- Patient perspectives on single-port versus multi-port robotic-assisted urologic oncology procedures: a survey-based analysis.Journal of robotic surgery · 2026Article
- Experiential learning in urologic single-port robotic surgery transition training: a qualitative descriptive study.Journal of robotic surgery · 2026Article
- Global research trends and hotspots in single-port robotic surgery in urology: a bibliometric analysis.Journal of robotic surgery · 2026Article
- Intelligent therapeutic robotic-assisted surgery as the next frontier of precision oncology.Frontiers in oncology · 2026Review
- Da Vinci Single-Port Robotic Surgery in Europe: Where Do We Stand? A Systematic Review.Journal of clinical medicine · 2025Review
- The Role of Robot-Assisted Radical Prostatectomy in the Management of Prostate Cancer and Future Perspectives.Cancers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The evolution of robotic surgery in urologic oncology has led to the emergence of single-port (SP) robotic systems as a potential alternative to the widely adopted multi-port (MP) platforms. This narrative review provides a comprehensive comparison between SP and MP robotic systems, the former of which received FDA approval in 2018 and CE marking in 2024, focusing on their application across radical prostatectomy, partial and radical nephrectomy, and radical cystectomy. Drawing from the most current literature, we examine perioperative outcomes, oncologic efficacy, postoperative recovery, and complication rates. The review highlights the technical challenges unique to SP surgery, including restricted triangulation, limited instrumentation, and a defined learning curve, while also emphasizing innovations such as transvesical prostatectomy and the Supine Anterior Retroperitoneal Access (SARA) approach. Additionally, we explore the potential impact of emerging technologies-such as artificial intelligence, augmented reality, and telesurgery-on the future of SP platforms. Despite early limitations, SP systems have demonstrated comparable safety and effectiveness in selected cases and may offer unique advantages in specific anatomical scenarios. Continued innovation, structured training, and robust long-term outcome data will be essential for the broader adoption and integration of SP robotic surgery in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.